組織學和細胞學市場－全球產業規模、佔有率、趨勢、機會和預測，按檢查類型、產品、應用、地區和競爭細分，2020-2030 年

2024 年全球組織學和細胞學市場價值為 173.7 億美元，預計在預測期內將達到 366.1 億美元，到 2030 年的複合年成長率為 13.19%。細胞學是生命科學的一個分支，涉及細胞的結構、功能和理解，而組織學則涉及生命形式細胞和組織的微觀解剖結構。組織學和細胞學致力於解釋動植物組織和細胞的結構，特別是在微觀層面。細胞學因其檢查速度快、精確性和價格合理，以及疾病盛行率高和用於子宮頸篩檢的測試而廣受歡迎。組織學和細胞學可以診斷許多傳染性和細胞疾病，例如子宮頸疾病、發炎性疾病、癌症和自體免疫疾病。組織學和細胞學市場在醫療保健行業中經歷了巨大的成長，因為許多疾病可以透過這些臨床研究來診斷。借助組織學和細胞學，可以識別多種傳染病，例如子宮頸疾病、癌症、異常生長、肝炎、發炎性疾病、腹瀉、白血病、天花、狂犬病等。從商業角度來看，細胞學和組織學用於診斷和研究程序。市場趨勢取決於製造商對這些臨床程序的試劑和試劑盒開發的偏好。

數位病理學、人工智慧輔助成像和自動化切片製備等先進技術在診斷實驗室的日益普及，進一步推動了全球組織學和細胞學市場的成長。這些創新技術提高了診斷準確性，減少了人為錯誤，並提升了工作流程效率。此外，遠距病理學的整合使病理學家能夠遠端檢查切片，這在農村或醫療資源匱乏的地區尤其有益，從而擴大了全球獲得高品質診斷服務的管道。

關鍵市場促進因素

癌症發生率不斷上升

主要市場挑戰

技術複雜性與成本

主要市場趨勢

液體活體組織切片和循環生物標記

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球組織學與細胞學市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按檢查類型（組織學、細胞學）
  • 按產品（儀器和分析軟體系統、消耗品和試劑）
  • 按應用（藥物發現與設計、臨床診斷、研究）
  • 按地區（北美、歐洲、亞太、南美、中東和非洲）
  • 按公司分類（2024）
• 市場地圖
• 按考試類型
• 按產品
• 按應用
• 按地區

第6章：北美組織學與細胞學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲組織學與細胞學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太組織學與細胞學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲組織學與細胞學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲組織學和細胞學市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球組織學與細胞學市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Kimberly Hologic, Inc.
• F Hoffmann-La Roche AG.
• Abbott Laboratories Inc.
• Becton Dickinson & Co.
• Danaher Corporation.
• Merck KGaA.
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation.
• Trivitron Healthcare.
• Koninklijke Philips NV

第 16 章：策略建議

第17章調查會社について,免責事項

Global Histology and Cytology Market was valued at USD 17.37 billion in 2024 and is expected to reach USD 36.61 billion in the forecast period with a CAGR of 13.19% through 2030. Cytology is a branch of life science concerned with the structure, function, and understanding of cells, whereas histology is concerned with the microscopic anatomy of cells and tissues of life forms. Histology and cytology strive to explain the structure of animal and plant tissues and cells, particularly at the microscopic level. Cytology is quite popular due to its rapid examination rate, precision, and affordability, as well as the high disease prevalence and use of the test for cervix screening. The diagnosis of numerous infectious and cell-based disorders, such as cervical diseases, inflammatory diseases, cancer, and autoimmune diseases, is investigated using histology and cytology. The histology and cytology market has been witnessing massive growth in the healthcare industry as a number of diseases can be diagnosed through these clinical studies. With the aid of histology and cytology, a number of infectious diseases can be identified such as cervical disease, cancer, abnormal growth, hepatitis, inflammatory diseases, diarrhea, leukemia, smallpox, rabies etc. From the commercial perspective, cytology and histology are used in the diagnostic and research procedure. The market trends are determined along with the manufacturer's preference for the development of reagents and kits for these clinical procedures.

The increasing adoption of advanced technologies in diagnostic laboratories, such as digital pathology, AI-assisted imaging, and automated slide preparation, is further propelling the growth of the global histology and cytology market. These innovations enhance diagnostic accuracy, reduce manual errors, and improve workflow efficiency. Additionally, the integration of telepathology allows pathologists to remotely examine slides, which is especially beneficial in rural or underserved areas, thereby expanding access to high-quality diagnostics globally.

Key Market Drivers

Increasing prevalence of cancer

The rising global cancer burden is a major factor accelerating the growth of the Global Histology and Cytology Market. These medical disciplines, which focus on the microscopic examination of cells and tissues, are crucial for early and accurate cancer diagnosis. As cancer incidence continues to climb, particularly among aging populations, the demand for histopathological and cytological evaluations is growing rapidly. According to the International Agency for Research on Cancer (IARC), in 2022 there were approximately 20 million new cancer cases and 9.7 million cancer-related deaths globally figures expected to increase substantially in the coming decades.

Furthermore, the number of cancer screening procedures is rising, particularly in emerging economies with expanding healthcare infrastructure. Cytological methods such as the Pap smear remain essential for cervical cancer screening. According to the World Health Organization (WHO), over 90% of cervical cancer cases are preventable and treatable if detected early and managed appropriately placing histology and cytology at the heart of global cancer control strategies. The increased use of biopsy techniques to assess tumors has also led to a surge in histopathological evaluations, further driving market demand. Combined with advances in digital pathology, AI-powered diagnostics, and molecular cytology, these trends ensure strong growth for histology and cytology technologies in oncology.

In addition to diagnostics, the role of histology and cytology in therapeutic monitoring is gaining prominence. As more cancer patients undergo treatments like chemotherapy, immunotherapy, or targeted therapy, regular assessment of tissue samples helps monitor treatment response and detect any recurrence or resistance. This has fueled the integration of advanced cytological imaging systems and histological staining technologies in clinical laboratories and hospitals. The demand for accurate pathological interpretation has also led to growing collaborations between hospitals and diagnostic centers, further expanding access to histology and cytology services.

Key Market Challenges

Technological Complexity and Costs

Advanced histology and cytology technologies often require significant upfront investments in terms of equipment, software, training, and infrastructure. This can be a barrier for smaller clinics, hospitals, and research facilities with limited financial resources. The high initial investment can lead to slower adoption rates, especially in regions with budget constraints. Utilizing complex histology and cytology technologies requires a skilled workforce with specialized training. Training pathologists, technicians, and clinicians to effectively use and interpret data from these technologies can be time-consuming and costly. The scarcity of skilled personnel can further impede technology adoption. Technologically advanced equipment typically requires regular maintenance and updates to ensure optimal performance. The costs associated with maintenance, repairs, and software updates can add to the overall expenses for healthcare institutions. This ongoing financial commitment can be a deterrent, particularly for smaller facilities. Integrating new technology into existing healthcare systems and workflows can be challenging. Compatibility issues with existing systems and processes may arise, requiring additional investments in software development and integration solutions. These challenges can delay technology implementation and adoption.

Key Market Trends

Liquid Biopsies and Circulating Biomarkers

Liquid biopsies involve the analysis of biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs), present in blood or other bodily fluids. They enable early detection of diseases, including cancer, even before traditional symptoms manifest. This capability drives the demand for histology and cytology services that can identify and analyze these biomarkers accurately. Unlike traditional tissue biopsies, which require invasive procedures, liquid biopsies are minimally invasive. This approach reduces patient discomfort, risk, and recovery time. As liquid biopsies gain prominence, the demand for traditional histological and cytological procedures might decline for certain applications, but histology and cytology techniques are still essential for validating liquid biopsy results and providing comprehensive diagnoses. Liquid biopsies are often used in conjunction with traditional histology and cytology techniques. They can provide additional information about tumor heterogeneity, genetic mutations, and treatment responses that might not be apparent through tissue biopsies alone. The integration of liquid biopsy data enhances the overall diagnostic accuracy and treatment decision-making process. Circulating biomarkers provide valuable information about a patient's tumor characteristics, enabling the development of personalized treatment strategies. This demand for personalized medicine supports the growth of the histology and cytology market, as these techniques remain essential for understanding tissue-level details and providing comprehensive patient care.

Key Market Players

• Hologic, Inc.
• F Hoffmann-La Roche AG.
• Abbott Laboratories Inc.
• Becton Dickinson & Co.
• Danaher Corporation.
• Merck KGaA.
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation.
• Trivitron Healthcare.
• Koninklijke Philips N.V.

Report Scope:

In this report, the Global Histology and Cytology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Histology and Cytology Market, By Type of Examination:

• Histology
• Cytology

Histology and Cytology Market, By Product:

• Instruments and Analysis Software System
• Consumable and Reagents

Histology and Cytology Market, By Application:

• Drug Discovery & Designing
• Clinical Diagnostics
• Research

Histology and Cytology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Histology and Cytology Market.

Available Customizations:

Global Histology and Cytology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Histology and Cytology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type Of Examination (Histology, Cytology)
  • 5.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 5.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Type of Examination
• 5.3.2 By Product
• 5.3.3 By Application
• 5.3.4 By Region

6. North America Histology and Cytology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type Of Examination (Histology, Cytology)
  • 6.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 6.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Histology and Cytology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Examination
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Histology and Cytology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Examination
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Histology and Cytology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Examination
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application

7. Europe Histology and Cytology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type Of Examination (Histology, Cytology)
  • 7.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 7.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Histology and Cytology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Examination
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Histology and Cytology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Examination
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Histology and Cytology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Examination
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Histology and Cytology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Examination
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Histology and Cytology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Examination
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application

8. Asia-Pacific Histology and Cytology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type Of Examination (Histology, Cytology)
  • 8.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 8.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Histology and Cytology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Examination
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
  • 8.3.2. India Histology and Cytology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Examination
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Histology and Cytology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Examination
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Histology and Cytology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Examination
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Histology and Cytology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Examination
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application

9. South America Histology and Cytology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type Of Examination (Histology, Cytology)
  • 9.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 9.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Histology and Cytology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Examination
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Histology and Cytology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Examination
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Histology and Cytology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Examination
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application

10. Middle East and Africa Histology and Cytology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type Of Examination (Histology, Cytology)
  • 10.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
  • 10.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Histology and Cytology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Examination
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Histology and Cytology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Examination
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Histology and Cytology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Examination
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Histology And Cytology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Kimberly Hologic, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. F Hoffmann-La Roche AG.
• 15.3. Abbott Laboratories Inc.
• 15.4. Becton Dickinson & Co.
• 15.5. Danaher Corporation.
• 15.6. Merck KGaA.
• 15.7. Thermo Fisher Scientific, Inc.
• 15.8. Sysmex Corporation.
• 15.9. Trivitron Healthcare.
• 15.10. Koninklijke Philips N.V.

16. Strategic Recommendations

17. About Us & Disclaimer